GlassScriptPhysician profile
Ruth Mcdonald
NPI 1538173687
$14,244.24
in general payments reported to CMS, 2019-2025
57 companies · $3,175 in 2025
The $3,175 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,182 · 2022: $2,204 · 2023: $3,061 · 2024: $2,622 · 2025: $3,175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,858.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,858.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,298.75 | 2021-2025 | |
| Novo Nordisk INC | $1,233.56 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $1,232.93 | 2021-2025 | Repatha, Repatha, Otezla |
| Pfizer INC. | $837.20 | 2021-2025 | |
| Glaxosmithkline, LLC. | $691.34 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Lilly USA, LLC | $691.17 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $673.79 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $641.73 | 2022-2025 | Caplyta |
| Bayer Healthcare Pharmaceuticals INC. | $593.51 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $544.15 | 2021-2024 | Austedo Xr, Austedo, Ajovy |
| Novartis Pharmaceuticals Corporation | $535.86 | 2021-2025 | |
| Biohaven Pharmaceuticals, INC. | $484.51 | 2021 | |
| Astellas Pharma US INC | $382.20 | 2021-2025 | Veozah, Myrbetriq |
| Amarin Pharma, INC. | $339.10 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $258.54 | 2021-2024 | Xarelto |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $239.91 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $220.65 | 2021-2025 | Verquvo, Gardasil 9, Capvaxive |
| Exact Sciences Corporation | $194.86 | 2023-2025 | Cologuard Collection Kit |
| Corium, LLC | $183.38 | 2023-2025 | Azstarys |
| Biohaven Pharmaceutical Holding Company LTD. | $176.28 | 2022 | |
| Daiichi Sankyo INC. | $172.04 | 2021-2025 | Injectafer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $128.93 | 2021-2025 | Jardiance |
| Gilead Sciences, INC. | $116.74 | 2025 | Yeztugo |
| Ucb, INC. | $107.54 | 2023-2024 | Nayzilam, Rystiggo |
| Myriad Genetic Laboratories, INC. | $103.65 | 2025 | Myrisk |
| Sanofi-Aventis U.S. LLC | $95.68 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $78.77 | 2024-2025 | Gemtesa |
| Axsome Therapeutics, INC. | $75.17 | 2023-2025 | Auvelity |
| Phathom Pharmaceuticals, INC. | $69.14 | 2023-2025 | Voquezna |
| Insulet Corporation | $58.29 | 2024-2025 | Omnipod |
| Biogen, INC. | $53.35 | 2025 | Zurzuvae |
| Alkermes, INC. | $51.65 | 2022-2023 | Aristada, Lybalvi |
| Otsuka America Pharmaceutical, INC. | $51.43 | 2023-2025 | Rexulti |
| Kowa Pharmaceuticals America, INC. | $46.30 | 2021-2022 | |
| Corcept Therapeutics | $45.37 | 2022-2023 | Korlym |
| Eisai INC. | $42.44 | 2021-2025 | |
| Shield Therapeutics INC | $41.40 | 2023-2024 | Accrufer |
| Neurocrine Biosciences, INC. | $35.79 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $35.72 | 2025 | Dupixent |
| Boston Scientific Corporation | $34.69 | 2025 | Watchman |
| Esperion Therapeutics, INC. | $34.19 | 2021-2025 | Nexletol |
| Ironwood Pharmaceuticals, INC | $32.51 | 2024-2025 | |
| Arbor Pharmaceuticals, INC. | $29.73 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $27.05 | 2023 | Belbuca, Xtampza |
| Amphastar Pharmaceuticals, INC. | $24.44 | 2025 | |
| Irhythm Technologies, INC. | $22.06 | 2022 | |
| Abbott Laboratories | $21.50 | 2025 | Freestyle Libre 3 |
| Ibsa Pharma INC. | $20.76 | 2024 | Tirosint, Licart |
| Almatica Pharma LLC | $20.12 | 2021 | |
| Sanofi Pasteur INC. | $15.82 | 2024 | |
| Seqirus USA INC | $15.57 | 2025 | Fluad, Flucelvax |
| Xeris Pharmaceuticals, INC. | $15.43 | 2024 | Gvoke Hypopen |
| Inspire Medical Systems, INC. | $14.99 | 2025 | Inspire |
| Amneal Pharmaceuticals LLC | $14.67 | 2025 | Unithroid |
| Vertex Pharmaceuticals Incorporated | $14.20 | 2025 | |
| Cequr Corporation | $12.55 | 2025 | Cequr Simplicity |
| Lundbeck LLC | $11.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruth Mcdonald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.